Cerus (CERS) EPS (Basic) (2010 - 2026)

Cerus (CERS) posted EPS (Basic) of -$0.01 for Q2 2026, down 75.15% sequentially from -$0.01 in Q1 2026, and up 50.23% YoY from -$0.01 in Q2 2025.

Cerus (CERS) EPS (Basic) (2010 - 2026) Analysis & Trends

Cerus has reported EPS (Basic) for 17 years, with the latest figure at -$0.01 in Q2 2026.

Quarterly EPS (Basic) rose 50.23% year-over-year to -$0.01 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$0.03 (up 63.6% YoY) and the FY2025 annual result came in at -$0.08, up 17.21% from the prior year.
EPS (Basic) fell to -$0.01 in Q2 2026 per CERS's latest filing, from -$0.01 in the prior quarter.
Over five years, EPS (Basic) peaked at $0.03 in Q4 2023 and troughed at -$0.09 in Q1 2023.
A 5-year average of -$0.03 and a median of -$0.03 in 2024 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2022 and 2023: EPS (Basic) plunged 362.47% in 2022, then soared 213.78% in 2023.
Over 5 years, EPS (Basic) stood at -$0.03 in 2022, then jumped by 213.78% to $0.03 in 2023, then plunged by 75.81% to $0.01 in 2024, then plunged by 170.41% to -$0.01 in 2025, then sank by 170.65% to -$0.01 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.01, -$0.01, and -$0.01 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.53
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	3.33
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.98
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.42
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.65
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	2.06
10	Cerus	560.58 Mn	504.32 Mn	29.53 Mn	-0.01

Download Data